47
Views
45
CrossRef citations to date
0
Altmetric
Article

Hsp70 Is a Novel Posttranscriptional Regulator of Gene Expression That Binds and Stabilizes Selected mRNAs Containing AU-Rich Elements

, , , , , & show all
Pages 71-84 | Received 17 Sep 2012, Accepted 17 Oct 2012, Published online: 20 Mar 2023

REFERENCES

  • Garneau NL, Wilusz J, Wilusz CJ. 2007. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 8:113–126.
  • Hargrove JL, Schmidt FH. 1989. The role of mRNA and protein stability in gene expression. FASEB J. 3:2360–2370.
  • Wu X, Brewer G. 2012. The regulation of mRNA stability in mammalian cells: 2.0. Gene 500:10–21.
  • Barreau C, Paillard L, Osborne HB. 2005. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33:7138–7150.
  • Chen C-YA, Shyu A-B. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465–470.
  • Halees AS, El-Badrawi R, Khabar KSA. 2008. ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse. Nucleic Acids Res. 36:D137–D140.
  • Blackshear PJ. 2002. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem. Soc. Trans. 30:945–952.
  • Chen C-YA, Xu N, Shyu A-B. 2002. Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization. Mol. Cell. Biol. 22:7268–7278.
  • Raineri I, Wegmueller D, Gross B, Certa U, Moroni C. 2004. Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res. 32:1279–1288.
  • Zhang T, Kruys V, Huez G, Gueydan C. 2002. AU-rich element-mediated translational control: complexity and multiple activities of trans-acting factors. Biochem. Soc. Trans. 30:952–958.
  • Paschoud S, Dogar AM, Kuntz C, Grisoni-Neupert B, Richman L, Kuhn LC. 2006. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol. Cell. Biol. 26:8228–8241.
  • Sarkar B, Xi Q, He C, Schneider RJ. 2003. Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol. Cell. Biol. 23:6685–6693.
  • Liao B, Hu Y, Brewer G. 2007. Competitive binding of AUF1 and TIAR to MYC mRNA controls its translation. Nat. Struct. Mol. Biol. 14:511–518.
  • Sanduja S, Blanco FF, Young LE, Kaza V, Dixon DA. 2012. The role of tristetraprolin in cancer and inflammation. Front. Biosci. 17:174–188.
  • Zhang J, Chen X. 2008. Posttranscriptional regulation of p53 and its targets by RNA-binding proteins. Curr. Mol. Med. 8:845–849.
  • Henics T, Nagy E, Oh HJ, Csermely C, von Gabain A, Subjeck JR. 1999. Mammalian Hsp70 and Hsp110 proteins bind to RNA motifs involved in mRNA stability. J. Biol. Chem. 274:17318–17324.
  • Wilson GM, Sutphen K, Bolikal S, Chuang K, Brewer G. 2001. Thermodynamics and kinetics of Hsp70 association with A+U-rich mRNA-destabilizing sequences. J. Biol. Chem. 276:44450–44456.
  • Laroia G, Cuesta R, Brewer G, Schneider RJ. 1999. Control of mRNA decay by heat shock-ubiquitin-proteosome pathway. Science 284:499–502.
  • Bukau B, Weissman J, Horwich A. 2006. Molecular chaperones and protein quality control. Cell 125:443–451.
  • Mayer MP, Bukau B. 2005. Hsp70 chaperones: Cellular functions and molecular mechanism. Cell. Mol. Life Sci. 62:670–684.
  • Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. 2006. Heat shock proteins 27 and 70: Anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5:2592–2601.
  • Richter K, Haslbeck M, Buchner J. 2010. The heat shock response: life on the verge of death. Mol. Cell 40:253–266.
  • Stankiewicz AR, Lachapelle G, Foo CPZ, Radicioni SM, Mosser DD. 2005. Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J. Biol. Chem. 280:38729–38739.
  • Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. 2006. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem. Sci. 31:164–172.
  • Li H, Sui C, Kong F, Zhang H, Liu J, Dong M. 2007. Expression of HSP70 and JNK-related proteins in human liver cancer: potential effects on clinical outcome. Dig. Liv. Dis. 39:663–670.
  • Thanner F, Sütterlin MW, Kapp M, Rieger L, Kristen P, Dietl J, Gassel AM, Müller T. 2003. Heat-shock protein 70 as a prognostic marker in node-negative breast cancer. Anticancer Res. 23:1057–1062.
  • Gabai VL, Budagova KR, Sherman MY. 2005. Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene 24:3328–3338.
  • Li G, Xu Y, Guan D, Liu Z, Liu DX. 2011. HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation. J. Biol. Chem. 286:20251–20259.
  • Gabai VL, Yaglom JA, Waldman T, Sherman MY. 2009. Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol. Cell. Biol. 29:559–569.
  • Rohde M, Daugaard M, Jensen MH, Nylandsted J, Jäättelä M. 2005. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev. 19:570–582.
  • Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV. 2006. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection. Cell Death Differ. 13:1434–1441.
  • Evans CG, Chang L, Gestwicki JE. 2010. Heat shock protein 70 (Hsp70) as an emerging drug target. J. Med. Chem. 53:4585–4602.
  • Meng L, Hunt C, Yaglom JA, Gabai VL, Sherman MY. 2011. Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 30:2836–2845.
  • Jindal S, Murray P, Rosenberg S, Young RA, Williams KP. 1995. Human stress protein hsp70: overexpression in E. coli, purification and characterization. Nat. Biotechnol. 13:1105–1109.
  • Lippincott J, Apostol I. 1999. Carbamylation of cysteine: a potential artifact in peptide mapping of hemoglobins in the presence of urea. Anal. Biochem. 267:57–64.
  • Wilson GM. 2005. RNA folding and RNA-protein binding analyzed by fluorescence anisotropy and resonance energy transfer, p 223–243. In Geddes CD, Lakowicz JR (ed), Reviews in fluorescence, vol 2. Springer Science+Business Media, Inc., New York, NY.
  • Fialcowitz-White EJ, Brewer BY, Ballin JD, Willis CD, Toth EA, Wilson GM. 2007. Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNA-destabilizing sequences. J. Biol. Chem. 282:20948–20959.
  • Santoro MM, Bolen DW. 1988. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl a-chymotrypsin using different denaturants. Biochemistry 27:8063–8068.
  • Manyusa S, Whitford D. 1999. Defining folding and unfolding reactions of apocytochrome b5 using equilibrium and kinetic fluorescence measurements. Biochemistry 38:9533–9540.
  • Fialcowitz EJ, Brewer BY, Keenan BP, Wilson GM. 2005. A hairpin-like structure within an AU-rich mRNA-destabilizing element regulates trans-factor binding selectivity and mRNA decay kinetics. J. Biol. Chem. 280:22406–22417.
  • Ysla RM, Wilson GM, Brewer G. 2008. Assays of adenylate uridylate-rich element-mediated mRNA decay in cells. Methods Enzymol. 449:47–71.
  • Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. 1998. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17:931–939.
  • Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM. 2009. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res. 69:5168–5176.
  • Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M. 2000. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J. 19:2340–2350.
  • Brewer BY, Malicka J, Blackshear PJ, Wilson GM. 2004. RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite nature of AU-rich mRNA-destabilizing motifs. J. Biol. Chem. 279:27870–27877.
  • Zucconi BE, Ballin JD, Brewer BY, Ross CR, Huang J, Toth EA, Wilson GM. 2010. Alternatively expressed domains of AU-rich element RNA-binding protein 1 (AUF1) regulate RNA-binding affinity, RNA-induced protein oligomerization, and the local conformation of bound RNA ligands. J. Biol. Chem. 285:39127–39139.
  • Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M. 2004. Identification of a target RNA motif for RNA-binding protein HuR. Proc. Natl. Acad. Sci. U. S. A. 101:2987–2992.
  • Wilson GM, Sun Y, Lu H, Brewer G. 1999. Assembly of AUF1 oligomers on U-rich RNA targets by sequential dimer association. J. Biol. Chem. 274:33374–33381.
  • Xin H, Brown JA, Gong C, Fan H, Brewer G, Gnarra JR. 2012. Association of the von Hippel-Lindau protein with AUF1 and posttranscriptional regulation of VEGFA mRNA. Mol. Cancer Res. 10:108–120.
  • Zhai B, Yang H, Mancini A, He Q-W, Antoniou J, Di Battista JA. 2010. Leukotriene B4 BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway. J. Biol. Chem. 285:23568–23580.
  • Leu JIJ, Pimkina J, Frank A, Murphy ME, George DL. 2009. A small molecule inhibitor of inducible heat shock protein 70. Mol. Cell 36:15–27.
  • Goldberg-Cohen I, Furneaux H, Levy AP. 2002. A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J. Biol. Chem. 277:13635–13640.
  • Jafarifar F, Yao P, Eswarappa SM, Fox PL. 2011. Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 30:1324–1334.
  • Maugeri N, Radhakrishnan J, Knight JC. 2010. Genetic determinants of HSP70 gene expression following heat shock. Hum. Mol. Genet. 19:4939–4947.
  • Kim HS, Wilce MCJ, Yoga YMK, Pendini NR, Gunzburg MJ, Cowieson NP, Wilson GM, Williams BRG, Gorospe M, Wilce JA. 2011. Different modes of interaction by TIAR and HuR with target RNA and DNA. Nucleic Acids Res. 39:1117–1130.
  • Ray D, Kazan H, Chan ET, Castillo LP, Chaudhry S, Talukder S, Blencowe BJ, Morris Q, Hughes TR. 2009. Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins. Nat. Biotechnol. 27:667–670.
  • Hudson BD, Martinez-Yamout MA, Dyson HJ, Wright PE. 2004. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat. Struct. Mol. Biol. 11:257–264.
  • Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. 2004. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 23:3092–3102.
  • Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M, Ascano M, Tuschl T, Ohler U, Keene JD. 2011. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol. Cell 43:327–339.
  • Stoecklin G, Tenebaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ, Anderson P. 2008. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 283:11689–11699.
  • Marucci A, Miscio G, Padovano L, Boonyasrisawat W, Florez J, Doria A, Trischitta V, Di Paola R. 2009. The role of HSP70 on ENPP1 expression and insulin-receptor activation. J. Mol. Med. 87:139–144.
  • Pavithra L, Sreenath K, Singh S, Chattopadhyay S. 2010. Heat-shock protein 70 binds to a novel sequence in 5′ UTR of tumor suppressor SMAR1 and regulates its mRNA stability upon prostaglandin A2 treatment. FEBS Lett. 584:1187–1192.
  • Doller A, Pfeilschifter J, Eberhardt W. 2008. Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell. Signal. 20:2165–2173.
  • Benjamin D, Moroni C. 2007. mRNA stability and cancer: an emerging link. Expert Opin. Biol. Ther. 7:1515–1529.
  • Denkert C, Weichert W, Winzer K-J, Muller B-M, Noske A, Niesporek S, Kristiansen G, Guski H, Dietel M, Hauptmann S. 2004. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin. Cancer Res. 10:5580–5586.
  • Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H, Furneaux H, Hla T, Haglund C, Ristimaki A. 2005. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res. 65:2157–2161.
  • Al-Souhibani N, Al-Ahmadi W, Hesketh JE, Blackshear PJ, Khabar KSA. 2010. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene 29:4205–4215.
  • Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, Pages G. 2007. Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol. Biol. Cell 18:4648–4658.
  • Buchan JR, Parker R. 2009. Eukaryotic stress granules: the ins and outs of translation. Mol. Cell 36:932–941.
  • Matsui H, Asou H, Inaba T. 2007. Cytokines direct the regulation of Bim mRNA stability by heat-shock cognate protein 70. Mol. Cell 25:99–112.
  • Duttagupta R, Vasudevan S, Wilusz CJ, Peltz SW. 2003. A yeast homologue of Hsp70, Ssa1p, regulates turnover of the MFA2 transcript through its AU-rich 3′ untranslated region. Mol. Cell. Biol. 23:2623–2632.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.